Maravai LifeSciences Holdings, Inc.
MRVI
$2.06
$0.052.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.94% | -13.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.94% | -13.49% | |||
| Cost of Revenue | 4.49% | 1.68% | |||
| Gross Profit | -59.26% | -33.17% | |||
| SG&A Expenses | -4.07% | 5.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.40% | 3.73% | |||
| Operating Income | -36.83% | -78.27% | |||
| Income Before Tax | -13.31% | 73.52% | |||
| Income Tax Expenses | 2,414.29% | -102.25% | |||
| Earnings from Continuing Operations | -13.67% | 73.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 12.57% | -73.54% | |||
| Net Income | -14.53% | 73.60% | |||
| EBIT | -36.83% | -78.27% | |||
| EBITDA | -65.84% | -363.61% | |||
| EPS Basic | -13.23% | 73.64% | |||
| Normalized Basic EPS | -782.61% | -99.49% | |||
| EPS Diluted | -13.23% | 73.66% | |||
| Normalized Diluted EPS | -782.61% | -99.49% | |||
| Average Basic Shares Outstanding | 1.14% | 0.18% | |||
| Average Diluted Shares Outstanding | 1.14% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||